subscribeSubscribe
price-trendAsk Us
Mereo BioPharma Receives FDA Fast Track Designation for Alvelestat

Mereo BioPharma Receives FDA Fast Track Designation for Alvelestat
GLOBENEWSWIRE
17 Oct 2022
Share Share
Mereo BioPharma’s Alvelestat Meets Endpoints in ASTRAEUS Trial in AATD

Mereo BioPharma’s Alvelestat Meets Endpoints in ASTRAEUS Trial in AATD
TRIALSITENEWS
10 May 2022
Share Share
Mereo Announces Initiation of Placebo-Controlled Ph 1b/2 Trial with Alvelestat

Mereo Announces Initiation of Placebo-Controlled Ph 1b/2 Trial with Alvelestat
GLOBENEWSWIRE
25 Aug 2020
Share Share
Celgene says no to Mereo’s cancer drug etigilimab

Celgene says no to Mereo’s cancer drug etigilimab
Phil Taylor PM LIVE
22 Jun 2019
Share Share